Evidence map›Paper›PMID 40055937›Full record

ArticleFEBS letters2025

Unconventional mRNA processing and degradation pathways for the polycistronic yrzI (spyTA) mRNA in Bacillus subtilis.

Laetitia Gilet, Magali Leroy, Alexandre Maes, Ciarán Condon, Frédérique Braun

Abstract read
In one paragraph

Article in FEBS letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Collided ribosomes are rescued by the endonuclease Rae1 andbioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laetitia GiletExpression Génétique Microbienne, CNRS - Université Paris Cité, Institut de Biologie Physico-Chimique, Paris, France.
Magali LeroyExpression Génétique Microbienne, CNRS - Université Paris Cité, Institut de Biologie Physico-Chimique, Paris, France.
Alexandre MaesPlateforme de Génomique Fonctionnel, UMR8226 CNRS Sorbonne Université, Institut de Biologie Physico-Chimique, Paris, France.
Ciarán CondonExpression Génétique Microbienne, CNRS - Université Paris Cité, Institut de Biologie Physico-Chimique, Paris, France.
Frédérique BraunExpression Génétique Microbienne, CNRS - Université Paris Cité, Institut de Biologie Physico-Chimique, Paris, France.ORCID https://orcid.org/0000-0001-5871-6042

Funding

Agence Nationale de la RechercheCNRS and Université Paris Cité UMR8261Equipex CacsiceLabEx Dynamo
6 · The paper itself

Abstract

The ribosome-associated endoribonuclease Rae1 cleaves the Bacillus subtilis yrzI operon mRNA in a translation-dependent manner. This operon encodes up to four small peptides, S1027, YrzI, S1025, and S1024, whose functions are unknown. Here, we identified the function of YrzI and S1025 and deciphered the degradation pathways of the yrzI polycistronic mRNA. We show that YrzI is toxic at high concentrations, but co-expression with S1025 abolishes its toxicity, and that, in the absence of Rae1, S1025 is the major antidote to the YzI toxin. We show that a highly stable mRNA species containing the YrzI and S1025 open reading frames results from endoribonucleolytic cleavage upstream of yrzI followed by the arrest of 5'-exoribonucleolytic processing by ribosomes bound to its exceptionally strong Shine-Dalgarno sequence. Degradation of this mRNA requires either translation-dependent cleavage within S1025 by Rae1 or direct attack from the structured 3'-end by 3'-exoribonucleases. Neither pathway is common for a B. subtilis mRNA.

Indexed as

Bacillus subtilisBacterial ProteinsRNA, BacterialRNA, MessengerRNA Processing, Post-TranscriptionalRNA StabilityEndoribonucleasesOperonRibosomesBacterial ProteinsEndoribonucleasesRNA, BacterialRNA, MessengerB. subtilisRae1RNA maturation and decayRNasestranslation

Identifiers

PMID40055937
PMCPMC12067863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.